Iain Dukes - 21 Dec 2021 Form 4 Insider Report for Ikena Oncology, Inc. (IKNA)

Role
Director
Signature
/s/ Douglas R. Carlson, as Attorney-in-Fact for Iain D. Dukes
Issuer symbol
IKNA
Transactions as of
21 Dec 2021
Net transactions value
$0
Form type
4
Filing time
23 Dec 2021, 17:39:18 UTC
Previous filing
06 Oct 2021
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKNA Stock Option (Right to Buy) Award $0 +23,419 $0.000000 23,419 21 Dec 2021 Common Stock 23,419 $14.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest (1) 25% on December 21, 2022, and the remaining shall vest in equal monthly installments over the next 36 months.